• There are no suggestions because the search field is empty.

Recent Posts by Charles F. Saller, Ph.D., President & CEO

 
Prior to founding ABS, Dr. Saller led the biochemical team at what is now AstraZeneca that worked on the discovery of Seroquel®, one of the most successful drugs of all time both in respect to therapeutic efficacy for psychiatric disorders and market value. Dr. Saller is a serial entrepreneur, having founded Saller Rental Properties in the 1980s, which provided the capital for founding ABS in January 1990. He continues to lead ABS operations and direct its strategy. Dr. Saller has also served as the Principal Investigator or has administered more than $5 million in government grants and contracts as a founder of one other bioscience company and as advisor to others.
Find me on:

Information-Sharing Best Practices

Information is the oxygen of an organization. Restrict it and productivity is starved. Share it effectively, and workflows are faster, more productive, and innovation can flourish. The free sharing of ideas lead to inclusion and innovation. Too often, organizations and individuals foster secrecy by either not trusting their employees or based upon misguided effort to control operations by limiting information access. This lack of trust is often fear based.

Read More

A New Way to Speed the Growth of Early-Stage Bioscience Companies

The critical work of discovering new therapies and new diagnostics is a long and resource intensive process. Too often important, but non-core tasks, delay the real work of discovery. ABS’ goal is to enable scientists and their companies to succeed more quickly by freeing their resources for mission critical activities.

Read More

New Beginnings

Happy New Year to all our readers! We wish you good health and happiness in the coming year. At this time of year, many of us make plans and resolutions. Similarly, at ABS, we map out our year and beyond.

Read More

External Sources of Innovation

Our primary source of ideas for innovation is founded in the challenges and concerns of our clients and staff. ABS began thirty-one years ago based upon the observation that a large amount of a researcher’s time was often spent growing cells and sourcing and preparing tissues (both animal and human) prior to even beginning an actual experiment. These tasks delayed discovery and expended valuable resources. This knowledge led us to become the first company to address this problem by providing custom cell culture services, prepared membranes and cell extracts, and founding a global network of human biospecimen collection sites. Today, such outsourcing is commonplace. In 1990, it was highly innovative.

Read More

Employees and Change

In a growing organization, employees should be the key drivers of change. They can also put the brakes on new innovations if they are not an integral part of the change process. It is the collaborative interactions between clients, staff, and management that make meaningful changes happen.

Read More

How Do We Know What to Change?

The previous post discussed the need for change in a changing world. That the world and business are rapidly evolving is obvious. The challenge is to decide, of those things that we can control, what should we change?

Read More

Why Change?

During difficult times the answer is simple: The status quo isn’t working. During good times, the argument for change is more questionable. ABS is growing at a high rate. So why are we discussing change? Why change when what we are doing is working? Why should any organization embrace change? During good or challenging times, change is difficult. In the first case, resources may already be strained and putting out fires may have become a full-time occupation. In the latter case, complacency, fear, inertia, and fallacy that the good times will just continue are obstacles to change and innovation. However, it is during the good times that change can lead to greater rewards than mere survival.

Read More

Major ABS Expansion

ABS was founded in 1990. We grew steadily during the subsequent years. We added new staff and new products and services that complemented our human biospecimen and cell culture services. Nearly two decades ago, we highly computerized our operations. We developed our systems for scalability. We became ISO9001 certified to ensure client-focus quality processes. Now, we are in position to capitalize upon those efforts.

Read More

COVID Vaccination, Running Red Lights, and Drunk Driving

What do these three things have in common? There are a lot of parallels. Even though the scientific evidence overwhelmingly indicates that the risks of COVID infection are far greater than the potential and unlikely side-effects of COVID vaccination, one can avoid or delay vaccination. One can choose not to get vaccinated and view this as a personal choice. This is clearly a personal choice, but it is also far more than that. This is where the analogy with running red lights comes into play.

Read More

Fear

Several years ago, I came across this written on a wall at an art exhibition in Venice and took the above photo. It is a good follow on from my previous posting on change in business and also those on COVID. So often people are afraid to take the next step that could move them forward because of fear.

Read More

Subscribe Here!